Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan;65(1):50-57.
doi: 10.1111/trf.18069. Epub 2024 Nov 27.

RhD-negative red blood cells can be saved during liver transplantation in RhD-negative patients due to low risk of alloimmunization against RhD

David Juhl  1 , Felix Braun  2 , Christian Brockmann  1 , Ingrid Musiolik  1 , Tina Bunge-Philipowski  1 , Kathrin Luckner  1 , Siegfried Görg  1 , Malte Ziemann  1
Affiliations

RhD-negative red blood cells can be saved during liver transplantation in RhD-negative patients due to low risk of alloimmunization against RhD

David Juhl et al. Transfusion. 2025 Jan.

Abstract

Background: Transfusion demand is high in liver transplantation (LT), and thus RhD-positive (RhD+) red blood cell concentrates (RBCs) are sometimes given to RhD-negative (RhD-) patients. Due to immunosuppression, these patients rarely produce anti-D. We investigated the rate of anti-D formation in RhD- patients undergoing LT who were transfused with RhD+ RBCs as well as the number of transfused RhD- and RhD+ RBCs.

Study design and methods: RhD-type and transfusion history of all patients undergoing LT between 2010 and 2023 were reviewed retrospectively. In RhD- patients, who received RhD+ RBCs, the results of antibody screening test (indirect antiglobulin test and with papain-treated test cells) and direct antiglobulin test were evaluated.

Results: Five hundred and twenty-seven patients underwent 576 LT. Eighty-seven patients were RhD-, of whom 42 were transfused with RhD+ RBCs. In 34 of them, an antibody screening test result was available more than two weeks after the last RhD+ RBCs transfusion. In two of them, a transient, weak anti-D antibody was detectable, which disappeared in the further course. Overall, 1352 RBCs were transfused to the 87 RhD- patients, 543 of those were RhD+. Most RhD+ RBCs were provided to men and elder women.

Discussion: Transient weak anti-D occurred in two RhD- male patients during LT after transfusion of RhD+ RBCs without evidence for a hemolytic transfusion reaction. To save stocks of RhD- RBCs, early transfusion of RhD+ RBCs to RhD- men and women beyond the childbearing age should be considered during LT.

Keywords: Rhesus‐incompatible transfusion of erythrocytes; blood management; transfusion practices (surgical); transplantation—solid organ.

PubMed Disclaimer

Similar articles

See all similar articles

References

REFERENCES

    1. Raval JS, Madden KM, Neal MD, Moore SA. Anti‐D alloimmunization in Rh(D) negative adults with severe traumatic injury. Transfusion. 2021;61:144–149.
    1. Frohn C, Dümbgen L, Brand JM, Görg S, Luhm J, Kirchner H. Probability of anti‐D development in D‐ patients receiving D+ RBCs. Transfusion. 2003;43:893–898.
    1. Yazer MH, Triulzi DJ, Sperry JL, Seheult JN. Rate of RhD‐alloimmunization after the transfusion of multiple RhD‐positive primary red blood cell‐containing products. Transfusion. 2021;61(Suppl 1):S150–S158.
    1. Boctor FN, Ali NM, Mohandas K, Uehlinger J. Absence of D‐alloimmunization in AIDS patients receiving D‐mismatched RBCs. Transfusion. 2003;43:173–176.
    1. Evers D, Zwaginga JJ, Tijmensen J, Middelburg RA, de Haas M, de Vooght KMK, et al. Treatments for hematologic malignancies in contrast to those for solid cancers are associated with reduced red cell alloimmunization. Haematologica. 2017;102:52–59.

LinkOut - more resources